These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 7594063

  • 1. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
    Brevetti G, Perna S, Sabbá C, Martone VD, Condorelli M.
    J Am Coll Cardiol; 1995 Nov 15; 26(6):1411-6. PubMed ID: 7594063
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment.
    Mikhailova TL, Sishkova E, Poniewierka E, Zhidkov KP, Bakulin IG, Kupcinskas L, Lesniakowski K, Grinevich VB, Malecka-Panas E, Ardizzone S, D'Arienzo A, Valpiani D, Koch M, Denapiene G, Vago G, Fociani P, Zerbi P, Ceracchi M, Camerini R, Gasbarrini G.
    Aliment Pharmacol Ther; 2011 Nov 15; 34(9):1088-97. PubMed ID: 21929562
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov 15; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 10. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM, Messina J, Xie F, Hale M.
    Clin Ther; 2007 Apr 15; 29(4):588-601. PubMed ID: 17617282
    [Abstract] [Full Text] [Related]

  • 11. The novel phosphodiesterase inhibitor NM-702 improves claudication-limited exercise performance in patients with peripheral arterial disease.
    Brass EP, Anthony R, Cobb FR, Koda I, Jiao J, Hiatt WR.
    J Am Coll Cardiol; 2006 Dec 19; 48(12):2539-45. PubMed ID: 17174195
    [Abstract] [Full Text] [Related]

  • 12. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar 19; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 13. Effect of propionyl-L-carnitine on quality of life in intermittent claudication.
    Brevetti G, Perna S, Sabba C, Martone VD, Di Iorio A, Barletta G.
    Am J Cardiol; 1997 Mar 15; 79(6):777-80. PubMed ID: 9070558
    [Abstract] [Full Text] [Related]

  • 14. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL, Gelso E.
    Drugs Exp Clin Res; 2002 Mar 15; 28(1):37-48. PubMed ID: 12073766
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A, Wyndaele JJ, Sieber P.
    Am J Geriatr Pharmacother; 2006 Mar 15; 4(1):14-24. PubMed ID: 16730617
    [Abstract] [Full Text] [Related]

  • 16. Propionyl-L-carnitine improves exercise performance and functional status in patients with claudication.
    Hiatt WR, Regensteiner JG, Creager MA, Hirsch AT, Cooke JP, Olin JW, Gorbunov GN, Isner J, Lukjanov YV, Tsitsiashvili MS, Zabelskaya TF, Amato A.
    Am J Med; 2001 Jun 01; 110(8):616-22. PubMed ID: 11382369
    [Abstract] [Full Text] [Related]

  • 17. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct 01; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 18. L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trial.
    Goldenberg NA, Krantz MJ, Hiatt WR.
    Vasc Med; 2012 Jun 01; 17(3):145-54. PubMed ID: 22615190
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C.
    Ann N Y Acad Sci; 2004 Nov 01; 1033():79-91. PubMed ID: 15591005
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP.
    Am J Gastroenterol; 2009 Jun 01; 104(6):1452-9. PubMed ID: 19491859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.